Related Experiment Video
Updated: Mar 27, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
Refining the Parkinson's Disease Risk Estimator for Decline In Cognition Tool (PREDICT)
Tara C Carlisle1,2, Lauren B Gunn-Sandell3, William L Lippitt3
1Department of Neurology, Behavioral Neurology Section, University of Colorado School of Medicine, Aurora, Colorado.
Background:
Although cognitive decline in Parkinson disease (PD) is common, there are currently no easily accessible clinical tools to predict the risk of cognitive decline in PD.
Objective:
To refine a tool to predict cognitive decline in PD and identify potentially modifiable factors.
Methods:
We used neuropsychological scores from the Parkinson's Progression Markers Initiative de novo PD cohort to calculate a composite cognitive score (CCS) for each participant. Participants with a decrease of ≥0.5 SD in CCS between baseline and Year 4 were considered to have cognitive decline (PD-Decline), as predicted by conditional linear mixed modeling to account for nonignorable dropouts. We identified risk factors for PD-Decline using logistic regression and developed the PD Risk Estimator for Decline In Cognition Tool (PREDICT) scoring system using the regression β coefficients. The selected risk factors and the discriminative ability of the PREDICT scoring system were evaluated using bootstrapped samples.
Results:
Participants with excessive daytime sleepiness (odds ratio [OR]=2.8; 95% CI [1.3, 6.0]), moderate-severe motor symptoms (OR=2.6; 95% CI [1.2, 5.4]), and fewer years of formal education (OR=2.2; 95% CI [1.1, 4.1]) had significantly increased odds of being categorized as PD-decline. Possible PREDICT scores ranged from 0 to 3.5. The average bootstrap sensitivity and specificity were 59.9% and 43.5%, respectively.
Conclusion:
We identified excessive daytime sleepiness and moderate-severe motor symptoms as potentially modifiable factors. In the future, PREDICT may offer wider opportunities for personalized risk assessment and potential risk reduction.
More Related Videos
07:26Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
Published on: September 26, 2019
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease: Overview
Cognitive Development During Adulthood
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...